Oppenheimer & Co’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$99.9K Sell
39,500
-73,500
-65% -$188K ﹤0.01% 1641
2025
Q4
$377K Buy
113,000
+101,000
+842% +$359K 0.01% 1184
2025
Q3
$46K Sell
12,000
-10,000
-45% -$42K ﹤0.01% 1632
2025
Q2
$94.6K Sell
22,000
-12,000
-35% -$48.3K ﹤0.01% 1568
2025
Q1
$134K Sell
34,000
-9,500
-22% -$45K ﹤0.01% 1499
2024
Q4
$221K Buy
+43,500
New +$251K ﹤0.01% 1417

Other funds holding CLVT

Oppenheimer & Co's CLVT Position: Q1 2026 in Review

Oppenheimer & Co reduced its Clarivate (CLVT) stake by 65% in Q1 2026, selling an estimated $188K and leaving 39,500 shares worth $99.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1641.

Oppenheimer & Co first reported a position in CLVT in Q4 2024 and has held it in 6 quarters since. The position peaked at $377K in Q4 2025. 255 funds tracked by Wall St. Rank hold CLVT as of Q1 2026.

  • Oppenheimer & Co held 39,500 shares of Clarivate worth $99.9K as of Q1 2026.
  • Oppenheimer & Co sold 73,500 Clarivate shares in Q1 2026, an estimated $188K.
  • Clarivate made up ﹤0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1641 holding.
  • Oppenheimer & Co first reported a position in Clarivate in Q4 2024 and has held it in 6 quarters since.
  • Oppenheimer & Co's Clarivate position peaked at $377K in Q4 2025.
  • 255 funds tracked by Wall St. Rank held Clarivate as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.